Articles From: Imprivata Webinar to Outline Regulatory and Technology Requirements for Electronic Prescribing of Controlled Substances to In Celebration of Disney's "Alexander and the Terrible, Horrible, No Good, Very Bad Day" Mattress Firm is holding a "Terrific, Wonderful, Awesome, Very Good Night" Sleepstakes Contest


Imprivata ® (NYSE: IMPR), a leading provider of authentication, access management and secure communications solutions for the healthcare industry, today announced that the company will host a webinar titled “Electronic Prescribing of Controlled Substance Is Here, What Should You Do?” on Tuesday, October 21, 2014 at 1:00 p.m. EDT.
Sign-up for Imprivata Webinar to Outline Regulatory and Technology Requirements for Electronic Prescribing of Controlled Substances investment picks
Imprivata® (NYSE: IMPR), a leading provider of authentication and access management solutions for the healthcare industry, today announced financial results for the third quarter of fiscal 2014.
Sign-up for Imprivata, Inc. Reports Third Quarter 2014 Financial Results investment picks
2014/10/14
Keep the focus on improving the customer experience.
Sign-up for Improving the Customer Experience Tops Agenda at AudaExplore’s Annual Total Loss Summit investment picks
2014/11/3
Unique needs of Baby Boomers, Generation X, and Millennials require personalized and streamlined communications LAKE SUCCESS, N.Y. , Nov.
Sign-up for Improving the Participant Experience is a Key Part in Addressing the Nation's Retirement Savings Shortfall, according to Broadridge Research investment picks
Company's report shows infrastructure improvements also drive economic growth in New Jersey NEWARK, N.J. , Nov.
Sign-up for Improving the Resiliency of the Electric Grid is Central to PSEG's Sustainability Strategy investment picks
2014/9/24
MINNEAPOLIS , Sept.
Sign-up for IMRIS Announces Waiver and Amendment Agreement and Repricing of Warrants investment picks
18 US neurosurgeons from 9 leading institutions validate robot usability for final 510(k) submission deliverable MINNEAPOLIS, MN , Dec.
Sign-up for IMRIS completes SYMBIS Surgical System human factors study investment picks
IMRIS completes SYMBIS Surgical System human factors study Canada NewsWire MINNEAPOLIS, MN , Dec.
Sign-up for IMRIS completes SYMBIS Surgical System human factors study investment picks
Intraoperative neurosurgical imaging solutions from IMRIS among featured medical technologies at upcoming November conference in Minneapolis MINNEAPOLIS , Sept.
Sign-up for IMRIS Horseshoe headrest named Life Sciences Alley New Technology Showcase winner investment picks
Learn more about these state-of-the-art products at CNS annual meeting MINNEAPOLIS , Oct.
Sign-up for IMRIS intraoperative imaging solutions provide optimized visualization platform for emerging neurosurgical therapies investment picks
IMRIS intraoperative imaging solutions provide optimized visualization platform for emerging neurosurgical therapies Canada NewsWire Learn more about these state-of-the-art products at CNS annual meeting MINNEAPOLIS , Oct.
Sign-up for IMRIS intraoperative imaging solutions provide optimized visualization platform for emerging neurosurgical therapies investment picks
2014/10/29
IMRIS neurosurgical suite opens at Boca Raton Regional Hospital Canada NewsWire Marcus Neuroscience Institute becomes first in Florida with both VISIUS iMRI and iCT for intraoperative imaging without patient transport MINNEAPOLIS, MN , Oct.
Sign-up for IMRIS neurosurgical suite opens at Boca Raton Regional Hospital investment picks
2014/10/29
Marcus Neuroscience Institute becomes first in Florida with both VISIUS iMRI and iCT for intraoperative imaging without patient transport MINNEAPOLIS, MN , Oct.
Sign-up for IMRIS neurosurgical suite opens at Boca Raton Regional Hospital investment picks
2014/10/28
New order bookings of $6.1 million in third quarter resulted in ending backlog of $127.2 million ; Order bookings totaled $46.7 million year-to-date 2014 compared with $33 million for entire 2013 year; Quarterly revenues of $6.9 million were at high end of IMRIS' expectations; Company maintains guidance for 2014 full year WINNIPEG and MINNEAPOLIS , Oct.
Sign-up for IMRIS Reports Third-Quarter 2014 Financial Results investment picks
2014/10/22
WINNIPEG and MINNEAPOLIS, MN, Oct.
Sign-up for IMRIS to Hold Third Quarter 2014 Financial Results Conference Call investment picks
IMS Health (NYSE:IMS), the global provider of healthcare information and technology solutions, announced the decision to host its Software-as-a-Service commercial applications on Amazon Web Services (AWS). Through the AWS global footprint, IMS Health will offer life sciences organizations additional options for deploying and scaling the Nexxus ™ Commercial Application Suite and IMS One ™ intelligent cloud — providing fast, reliable and secure access to integrated sales and marketing information across critical commercial functions.
Sign-up for IMS Health Adopts Amazon Web Services to Expand Deployment Options, Increase Scalability of IMS One, Nexxus Commercial Application Suite investment picks
2014/9/23
As the global market for drugs surpasses $1 trillion this year, growing payer scrutiny of value for money is just one of the factors that will drive disruptive change in the use of medicines over the next decade, according to a report issued today by the IMS Institute for Healthcare Informatics.
Sign-up for IMS Health Identifies Ten Harbingers of Disruptive Change Forcing Adjustment to Healthcare Systems and Business Models investment picks
IMS Health (NYSE:IMS) today announced that following successful completion of works council information and consultation requirements in certain countries, the Cegedim Board of Directors has approved IMS Health’s offer to acquire certain Cegedim information solutions and Customer Relationship Management (CRM) businesses, and a definitive purchase agreement has been executed.
Sign-up for IMS Health Offer to Purchase Cegedim’s Information Solutions and CRM Businesses Approved by Cegedim Board investment picks
IMS Health Holdings , Inc. (“IMS Health”) (NYSE:IMS), a leading global provider of information and technology services to the healthcare and life sciences industries, today announced results for the quarter ended September 30, 2014.
Sign-up for IMS Health Reports Third-Quarter 2014 Results investment picks
2014/11/20
More specialty drug innovation, greater patient access to medicines and reduced impact from patent expiries will be the primary drivers of an increase in global medicine spending of up to 30 percent by 2018.
Sign-up for IMS Health Study Forecasts Global Spending on Medicines to Increase 30 Percent by 2018, to $1.3 Trillion investment picks
IMS Health Holdings, Inc. (“IMS Health”) (NYSE:IMS) will issue its financial results for third-quarter 2014 on Friday, October 24, 2014, before the market opens.
Sign-up for IMS Health to Announce Third-Quarter 2014 Results On October 24, 2014 investment picks
IMS Health (NYSE:IMS) announced today that the company will participate at the following investor conferences during the month of December: Live audio webcasts of these sessions will be available on the IMS Health Investor Relations website at http://ir.imshealth.com .
Sign-up for IMS Health to Participate in Credit Suisse Conference and Barclays Conference in December investment picks
IMS Health (NYSE:IMS) announced today that Stefan Linn, senior vice president, Strategy & Global Product Management, will participate in a “fireside chat” at the Leerink Partners Services Roundtable in New York City on Tuesday, September 30, 2014 at 12:05 p.m. Eastern Time.
Sign-up for IMS Health to Participate in Leerink Partners Services Roundtable on September 30, 2014 investment picks
IMS Health (NYSE:IMS) announced today that Ron Bruehlman, senior vice president and chief financial officer, will participate in a “fireside chat” at the Stifel Healthcare Conference in New York City on Wednesday, November 19, 2014 at 11:30 a.m. Eastern Time.
Sign-up for IMS Health to Participate in Stifel Healthcare Conference on November 19, 2014 investment picks
Imvescor Restaurant Group announces the appointment of three directors Canada NewsWire MONCTON, N.B. , Nov.
Sign-up for Imvescor Restaurant Group announces the appointment of three directors investment picks
Imvescor Restaurant Group declares $0.02 per common share dividend Canada NewsWire December 18, 2014 payment date December 11, 2014 record date MONCTON, NB , Nov.
Sign-up for Imvescor Restaurant Group declares $0.02 per common share dividend investment picks
2014/9/29
Marriott Leads in Engaging Consumers and Driving Business through Story-driven Creative and Projects in Film, TV, Music and Digital Entertainment BETHESDA, Md.
Sign-up for In An Industry First - Marriott International Makes Bold Marketing Move - Launches a Global Creative and Content Marketing Studio investment picks
2014/9/22
Enter for a chance to win $5,000, a Beautyrest queen-size mattress and more HOUSTON , Sept.
Sign-up for In Celebration of Disney's "Alexander and the Terrible, Horrible, No Good, Very Bad Day" Mattress Firm is holding a "Terrific, Wonderful, Awesome, Very Good Night" Sleepstakes Contest investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Imprivata Webinar to Outline Regulatory and Technology Requirements for Electronic Prescribing of Controlled Substances to In Celebration of Disney's "Alexander and the Terrible, Horrible, No Good, Very Bad Day" Mattress Firm is holding a "Terrific, Wonderful, Awesome, Very Good Night" Sleepstakes Contest
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent